RedHill Biopharma (RDHL) Divestments (2013 - 2022)

RedHill Biopharma (RDHL) has 10 years of Divestments data on file, last reported at -$22000.0 in Q3 2022.

• On a quarterly basis, Divestments rose 99.74% year-over-year to -$22000.0 in Q3 2022; TTM through Dec 2022 was $8.3 million, a 201.99% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 18888.89% from the prior year.
• Divestments for Q3 2022 stood at -$22000.0, up from -$163000.0 in the prior quarter.
• Over the last five years, Divestments for RDHL reached as high as $11.7 million in Q3 2019 and fell as low as -$48.7 million in Q4 2020.
• Historically, Divestments has averaged -$1.8 million across 5 years, with a median of $281000.0 in 2018.
• Across the five-year window, Divestments slumped 2897.71% in 2019 and surged 2093.02% in 2022, its largest moves.
• Year by year, Divestments stood at $175000.0 in 2018, then slumped by 2897.71% to -$4.9 million in 2019, then sank by 894.16% to -$48.7 million in 2020, then jumped by 107.18% to $3.5 million in 2021, then sank by 100.63% to -$22000.0 in 2022.
• Per Business Quant data, the three most recent Divestments figures were -$22000.0 in Q3 2022, -$163000.0 in Q2 2022, and $8.5 million in Q1 2022.